C-kit and PDGFRA gene mutations in triple negative breast cancer

被引:1
|
作者
Zhu, Yun [1 ]
Wang, Yan [3 ]
Guan, Bing [1 ]
Rao, Qiu [1 ]
Wang, Jiandong [1 ]
Ma, Henghui [1 ]
Zhang, Zhihong [2 ]
Zhou, Xiaojun [1 ]
机构
[1] Nanjing Univ, Nanjing Jinling Hosp, Coll Med, Dept Pathol,Clin Sch, Nanjing 210002, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing 210029, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Affiliated Hosp 2, Dept Pathol, Nanjing 210003, Jiangsu, Peoples R China
关键词
C-KIT; PDGFRA; mutation; triple negative breast cancer; immunohistochemical expression; GASTROINTESTINAL STROMAL TUMORS; CELL LUNG-CANCER; KINASE INHIBITOR; EXPRESSION; CARCINOMAS; DASATINIB; RECEPTOR; GROWTH; LINES;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, we evaluated C-kit immunohistochemical expression and C-kit and platelet derived growth factor receptor A (PDGFRA) gene mutations in triple negative breast cancer. 171 cases were analyzed by immunohistochemical staining for the expression of C-kit and 45 cases, including 10 C-kit negative cases and 35 C-kit positive cases, were performed for C-kit gene mutations in exons 9, 11, 13 and 17 and PDGFRA gene mutations in exons 12 and 18. C-kit expression was detected in 42.1% of triple negative breast cancers. Only 1 activating mutation was detected in exon 11 of C-kit gene in 1 case. No activating mutations were found in the other 44 cases. C-kit expression is a frequent finding in triple negative breast cancers; 1 activating mutation which was also found in gastrointestinal stromal tumors was detected; a few cases might benefit from imatinib.
引用
收藏
页码:4280 / 4285
页数:6
相关论文
共 50 条
  • [1] c-KIT and PDGFRA in breast phyllodes tumours: overexpression without mutations?
    Carvalho, S
    Silva, AOE
    Milanezi, F
    Ricardo, S
    Leitao, D
    Amendoeira, I
    Schmitt, FC
    JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (10) : 1075 - 1079
  • [3] C-KIT and PDGFRA expression in phyllodes tumor of the breast
    Jung, C.
    Suh, K.
    Chang, E.
    HISTOPATHOLOGY, 2008, 53 : 42 - 42
  • [4] ANALYSIS OF C-KIT AND PDGFRA GENE MUTATIONS IN GASTROINTESTINAL STROMALE TUMORS OF THE GASTROINTESTINAL TRACT
    Tsapkova, L. A.
    Filonenko, D. A.
    Khatkov, I. E.
    Bodunova, N. A.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (02): : 335 - 336
  • [5] Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines
    Dizdar, Omer
    Dede, Didem S.
    Bulut, Nilufer
    Altundag, Kadri
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 107 (02) : 303 - 303
  • [6] Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines
    Omer Dizdar
    Didem S. Dede
    Nilufer Bulut
    Kadri Altundag
    Breast Cancer Research and Treatment, 2008, 107 : 303 - 303
  • [7] Immunohistochemical Expression of Epidermal Growth Factor Receptor and c-Kit in Triple Negative Breast Cancer
    Ahmed, Rabia
    Din, Hafeez Ud
    Akhtar, Farhan
    Afzal, Saeed
    Muhammad, Iqbal
    Hashmi, Shoaib Naiyar
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2016, 26 (07): : 570 - 572
  • [8] Coexisting C-KIT and PDGFRA mutations in gastrointestinal stromal tumors (GIST)
    Jimeno, M.
    Martinez, L.
    Sanchez-Cid, L.
    Mojal, S.
    Juanpere, N.
    Garcia, P.
    Baro, T.
    Ribalta, T.
    Serrano, S.
    Bellosillo, B.
    Lloreta, J.
    LABORATORY INVESTIGATION, 2008, 88 : 123A - 123A
  • [9] DETECTION OF C-KIT AND PDGFRA MUTATIONS IN GIST BY NEXT GENERATION SEQUENCING
    Celine, De Rop
    Gabriela, Beniuga
    Placide, Ngendahayo
    Pascal, Vannuffel
    ANNALS OF ONCOLOGY, 2014, 25 : 14 - 14
  • [10] Coexisting C-KIT and PDGFRA mutations in gastrointestinal stromal tumors (GIST)
    Jimeno, M.
    Martinez, L.
    Sanchez-Cid, L.
    Mojal, S.
    Juanpere, N.
    Garcia, P.
    Baro, T.
    Ribalta, T.
    Serrano, S.
    Bellosillo, B.
    Lloreta, J.
    MODERN PATHOLOGY, 2008, 21 : 123A - 123A